Medtronic plc (MDT) | Stock Overview & Key Data

Medtronic plc | Healthcare

$86.11

2.21%

| Compare Stocks:

Medtronic plc vs Abbott Laboratories Medtronic plc vs Boston Scientific Medtronic plc vs Stryker Medtronic plc vs Edwards Lifesciences Medtronic plc vs Dexcom Medtronic plc vs S&P 500 | Market

Medtronic plc Performance Comparison

Loading chart data...

Medtronic plc

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $84.70 High: $86.12

on May 15, 2025

52 Week Range

Low: $75.96 High: $96.25

on July 9, 2024

on March 10, 2025

All-Time High: $135.89 on September 6, 2021

Key Statistics

Market Cap i $110.1B

EPS i 3.28

P/E Ratio (TTM) i 26.16

Forward P/E i 14.67

P/B Ratio i 2.23

PEG Ratio i 14.67

Div. Yield i 3.29%

ROE i 8.44%

Beta i 0.830

Debt to Equity i 53.63

Financial Highlights

Profitability

Gross Margin i 66.49%

Operating Margin i 21.95%

Profit Margin i 12.83%

Returns and Earnings

Return on Assets (TTM) i 4.66%

Return on Equity (TTM) i 8.44%

EBITDA i $9.0B

Net Income (TTM) i $4.3B

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Expected Yearly Dividend i $2.80

Estimated Dividend Yield i 3.29%

5 Year Average Dividend Yield i 2.77%

Last 12-Month Dividend Yield i 3.29%

Last 12-Month Dividend i $2.80

% of Earnings Paid as Dividends i 85.06%

Dividend Date i April 11, 2025

Ex-Dividend Date i March 28, 2025

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Medtronic plc MDT	110.05B Large-cap	2.98%	4.54%	0.05%	-1.62%	7.34%	0.20%	-16.03%	-9.11%
Abbott Laboratories ABT	223.67B Mega-cap	-0.46%	5.67%	2.46%	15.08%	17.58%	28.11%	17.76%	45.79%
Boston Scientific BSX	152.31B Large-cap	-1.74%	-2.80%	12.94%	20.38%	12.87%	47.05%	124.84%	173.74%
Stryker SYK	148.31B Large-cap	2.52%	13.06%	1.68%	0.52%	9.30%	17.07%	68.71%	112.78%
Edwards Lifesciences EW	45.02B Large-cap	0.64%	-0.99%	-4.49%	7.46%	-2.31%	-25.80%	-42.38%	12.52%
Dexcom DXCM	33.93B Large-cap	0.42%	23.79%	-5.34%	12.94%	9.17%	-34.78%	6.67%	-15.44%

Ownership & Short Interest

Insider Ownership i 0.26%

Institutional Ownership i 86.83%

Shares Short i 12M

Short Ratio i 1.67

Short % of Shares Outstanding i 0.96%

Average 10-Day Volume i 7M

Average 90-Day Volume i 7M

Medtronic plc Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Medtronic plc would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is MDT's 52-week high and low?

In the last 52 weeks, Medtronic plc reached a high of $96.25 (on March 10, 2025) and a low of $75.96 (on July 9, 2024).

What is the market cap and P/E ratio for MDT?

Curious about Medtronic plc's size and valuation? Its market capitalization stands at 110.05B. When it comes to valuation, the P/E ratio (trailing twelve months) is 26.16, and the forward P/E (looking ahead) is 14.67.

Does MDT pay dividends? If so, what's the yield?

Yes, Medtronic plc is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 3.29%, and the company is expected to pay out $2.80 per share over the coming year.

Who are Medtronic plc's main competitors or similar companies to consider before investing?

When looking at Medtronic plc, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Abbott Laboratories ABT	223.67B	Healthcare	Medical Devices	28.11%	17.76%
Boston Scientific BSX	152.31B	Healthcare	Medical Devices	47.05%	124.84%
Stryker SYK	148.31B	Healthcare	Medical Devices	17.07%	68.71%
Edwards Lifesciences EW	45.02B	Healthcare	Medical Devices	-25.80%	-42.38%
Dexcom DXCM	33.93B	Healthcare	Medical Devices	-34.78%	6.67%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Medtronic plc? (e.g., ROE, Debt/Equity)

To get a sense of Medtronic plc's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.44%, the Debt to Equity ratio from the most recent quarter is 53.63, and its Gross Profit Margin stands at 66.49%.

What is the recent revenue and earnings growth for MDT?

Looking at Medtronic plc's growth, its revenue over the trailing twelve months (TTM) was $33B. Compared to the same quarter last year (YoY), quarterly revenue grew by 2.50%, and quarterly earnings saw a YoY growth of -2.10%.

How much of MDT stock is held by insiders and institutions?

Wondering who owns Medtronic plc stock? Company insiders (like executives and directors) hold about 0.26% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 86.83%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.